Synthesis and evaluation of 6-heteroarylamino-2,4,5-trimethylpyridin-3-ols as inhibitors of TNF-α-induced cell adhesion and inflammatory bowel disease

MedChemComm
Sang Won ParkTae-Gyu Nam

Abstract

Inflammatory bowel disease (IBD) is an inflammatory disease of the gastrointestinal tract with complex pathogenesis. Here, we synthesized 6-heteroarylamino analogues to inhibit TNF-α-induced adhesion of monocytes to colon epithelial cells which are implicated in the initial inflammation process of IBD. The best analogue, 16a, showed IC50 = 0.29 μM, which is about five orders of magnitude better than that of 5-aminosalicylic acid (5-ASA), a positive control. Oral administration of 6f and 16a dramatically ameliorated 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colon inflammation in rat. The ameliorating effects were accompanied by a high level of recovery in colon and body weights and in the myeloperoxidase (MPO) level. Consistently, the compounds suppressed the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein 1 (MCP-1). Moreover, they significantly suppressed the expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 while increasing the level of IL-10, an anti-inflammatory cytokine.

References

Dec 1, 1988·Gastroenterology·E SekizukaD N Granger
Sep 24, 2004·Journal of Pharmacological and Toxicological Methods·Abdo R JurjusJean-Marie Reimund
Sep 1, 2005·Clinical Reviews in Allergy & Immunology·Raja Atreya, Markus F Neurath
Dec 24, 2005·The Journal of Pharmacology and Experimental Therapeutics·Naoki KobayashiTeruna J Siahaan
Nov 1, 2006·Inflammatory Bowel Diseases·Torsten KucharzikWolfram Domschke
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevin N CouperEleanor M Riley
Jun 17, 2011·Nature·Bernard KhorRamnik J Xavier
Jan 13, 2012·Annals of the New York Academy of Sciences·Erik-Oliver GlockerBodo Grimbacher
Oct 10, 2013·Current Drug Targets·Mariangela AlloccaSilvio Danese
Feb 1, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornUNKNOWN Study A3921043 Investigators
Apr 1, 2014·European Journal of Medicinal Chemistry·Dong-Guk KimByeong-Seon Jeong
Dec 23, 2014·Digestive Diseases·Bruce E Sands
Mar 19, 2015·The New England Journal of Medicine·Giovanni MonteleoneFrancesco Pallone
Aug 26, 2015·The American Journal of Gastroenterology·L Peyrin-BirouletJ-F Colombel
Sep 2, 2015·Nature Reviews. Gastroenterology & Hepatology·Gilaad G Kaplan
Dec 22, 2015·Current Opinion in Pharmacology·Ivana BravatàSilvio Danese
Jan 26, 2016·Pharmacology & Therapeutics·Caroline Meyer OlesenOle Haagen Nielsen
Sep 7, 2016·Bioorganic & Medicinal Chemistry Letters·Suhrid BanskotaTae-Gyu Nam
Feb 2, 2017·Nature Reviews. Gastroenterology & Hepatology·Markus F Neurath

❮ Previous
Next ❯

Citations

Aug 4, 2020·Bioorganic Chemistry·Chhabi Lal ChaudharyByeong-Seon Jeong
Aug 21, 2018·Chemico-biological Interactions·Jaya GautamJung-Ae Kim
Aug 4, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Bhuwan Prasad AwasthiByeong-Seon Jeong

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.